MOACM
DPLO

Mutual of America Capital Management’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Mutual of America Capital Management’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,063
Closed -$8K – 1708
2019
Q4 		$8K Sell
2,063
-78
-4% -$366 ﹤0.01% 1677
2019
Q3 		$10K Buy
2,141
+100
+5% +$560 ﹤0.01% 1657
2019
Q2 		$12K Buy
2,041
+408
+25% +$2.17K ﹤0.01% 1637
2019
Q1 		$9K Buy
1,633
+232
+17% +$2.4K ﹤0.01% 1653
2018
Q4 		$19K Buy
1,401
+333
+31% +$5.62K ﹤0.01% 1477
2018
Q3 		$21K Buy
1,068
+891
+503% +$19K ﹤0.01% 1468
2018
Q2 		$5K Buy
+177
New +$4.13K ﹤0.01% 1430

Other funds holding DPLO

GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

Mutual of America Capital Management's DPLO Position: Q1 2020 in Review

Mutual of America Capital Management sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 2,063 shares — an estimated $8K sold.

Mutual of America Capital Management first reported a position in DPLO in Q2 2018 and held it in 7 quarters. The position peaked at $21K in Q3 2018. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.

  • Mutual of America Capital Management reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
  • Mutual of America Capital Management sold 2,063 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $8K.
  • Mutual of America Capital Management first reported a position in DIPLOMAT PHARMACY, INC. in Q2 2018 and held it in 7 quarters.
  • Mutual of America Capital Management's DIPLOMAT PHARMACY, INC. position peaked at $21K in Q3 2018.
  • 1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.

Based on Mutual of America Capital Management's 13F filing for Q1 2020, filed 11 May 2020.